RaQualia Pharma Inc.JP:4579
| Dec 31,
2012 | Dec 31,
2013 | Dec 31,
2014 | Dec 31,
2015 | Dec 31,
2016 | Dec 31,
2017 | Dec 31,
2018 | Dec 31,
2019 | Dec 31,
2020 | Dec 31,
2021 | Dec 31,
2022 | Dec 31,
2023 |
|---|
| Profit (loss) before income taxes | -2,902 | -1,102 | -632 | -1,848 | -723 | -60 | -1,078 | 27 | -528 | 881 | 851 | -294 |
|---|
| Depreciation | - | 68 | 21 | 53 | 80 | 86 | 126 | 140 | 124 | 142 | 148 | 176 |
|---|
| Interest income | - | -1 | -34 | -4 | -13 | -4 | -9 | -9 | -4 | -2 | -1 | -3 |
|---|
| Interest income on securities | - | - | - | -78 | -52 | -35 | -32 | -35 | -28 | -21 | -13 | -6 |
|---|
| Interest expenses | - | - | - | - | - | - | - | - | 0 | 1 | 6 | 7 |
|---|
| Commitment fees | - | - | - | - | - | - | - | - | - | - | 6 | 9 |
|---|
| Foreign exchange losses (gains) | - | -63 | -52 | -14 | 12 | 7 | -26 | 11 | 68 | -114 | -31 | -46 |
|---|
| Loss (gain) on sale of investment securities | - | -801 | -1,544 | -66 | - | -17 | -5 | -6 | -8 | -14 | -10 | - |
|---|
| Loss (gain) on redemption of investment securities | - | - | - | 6 | 2 | - | 18 | - | 7 | -2 | -4 | 1 |
|---|
| Loss (gain) on valuation of investment securities | - | - | - | - | - | - | - | - | - | - | 50 | - |
|---|
| Loss (gain) on valuation of derivatives | - | - | - | - | - | - | - | - | - | 10 | -14 | 25 |
|---|
| Loss (gain) on valuation of compound financial instruments | - | - | -20 | 21 | -8 | 2 | 1 | -4 | -1 | -0 | 11 | -3 |
|---|
| Share issuance costs | - | 8 | 7 | 6 | - | - | 1 | 12 | 0 | 0 | 16 | 4 |
|---|
| Subsidy income | - | - | - | - | -20 | -44 | -1 | -0 | -1 | -6 | - | -3 |
|---|
| Retirement benefits for directors (and other officers) | - | - | - | - | - | - | - | - | - | - | 18 | - |
|---|
| Decrease (increase) in trade receivables | - | -50 | 40 | -53 | 15 | -381 | 448 | -747 | 216 | -675 | 603 | -1 |
|---|
| Decrease (increase) in inventories | - | 1 | 38 | 2 | 0 | 2 | -1 | 1 | -1 | -4 | 2 | -139 |
|---|
| Increase (decrease) in trade payables | - | - | - | - | - | 2 | -2 | 34 | 8 | 4 | 82 | -74 |
|---|
| Decrease (increase) in advance payments to suppliers | - | - | - | -121 | -26 | 15 | 181 | 3 | -30 | 20 | -74 | 23 |
|---|
| Decrease (increase) in prepaid expenses | - | - | - | -10 | 10 | -6 | -10 | 3 | 19 | -40 | -7 | -65 |
|---|
| Decrease (increase) in long-term prepaid expenses | - | - | - | - | - | - | - | - | - | - | - | -32 |
|---|
| Decrease (increase) in consumption taxes refund receivable | - | - | - | 6 | - | 18 | -14 | -5 | -56 | 63 | -24 | -91 |
|---|
| Increase (decrease) in accrued consumption taxes | - | - | - | - | - | - | -14 | - | - | 37 | -37 | - |
|---|
| Increase (decrease) in accounts payable - other | - | 37 | -21 | -46 | 9 | -20 | 11 | -7 | -23 | 68 | 76 | -46 |
|---|
| Increase (decrease) in accrued expenses | - | - | - | - | - | - | - | - | -1 | 13 | -3 | -6 |
|---|
| Increase (decrease) in income taxes payable - factor based tax | - | - | - | - | - | - | - | - | -4 | 14 | -7 | -9 |
|---|
| Increase (decrease) in deposits received | - | - | - | - | - | - | - | - | -0 | 26 | -10 | -15 |
|---|
| Increase (decrease) in provision for share awards | - | - | - | - | - | - | - | - | - | - | 61 | -12 |
|---|
| Increase (decrease) in provision for share awards for directors (and other officers) | - | - | - | - | - | - | - | - | - | - | 14 | -4 |
|---|
| Other, net | - | -90 | 122 | -63 | -13 | 48 | -7 | 31 | 2 | 1 | -33 | 11 |
|---|
| Subtotal | - | -2,172 | -2,021 | -2,095 | -728 | -390 | -414 | -552 | -234 | 426 | 1,676 | -596 |
|---|
| Interest and dividends received | - | 1 | 21 | 71 | 61 | 41 | 41 | 44 | 37 | 22 | 18 | 10 |
|---|
| Interest paid | - | - | - | - | - | - | - | - | -0 | -1 | -6 | -7 |
|---|
| Commitment fees paid | - | - | - | - | - | - | - | - | - | - | -7 | -19 |
|---|
| Income taxes paid | - | -6 | -9 | -6 | -2 | -2 | -32 | -24 | -93 | -77 | -184 | -122 |
|---|
| Income taxes refund | - | - | - | - | - | - | - | - | - | - | - | 12 |
|---|
| Subsidies received | - | - | - | - | 20 | 44 | 1 | 0 | 2 | 6 | - | 3 |
|---|
| Payments of retirement benefits for directors (and other officers) | - | - | - | - | - | - | - | - | - | - | -18 | - |
|---|
| Net cash provided by (used in) operating activities | - | -2,179 | -2,081 | -2,117 | -681 | -307 | -404 | -531 | -289 | 366 | 1,480 | -719 |
|---|
| Payments into time deposits | - | -50 | -511 | - | -324 | - | - | - | - | -318 | -200 | -100 |
|---|
| Proceeds from withdrawal of time deposits | - | 50 | 525 | - | - | 340 | - | 10 | - | 207 | 310 | - |
|---|
| Purchase of securities | - | - | -1,061 | -621 | -200 | -110 | - | - | - | -200 | -100 | - |
|---|
| Proceeds from redemption of securities | - | - | - | 1,557 | 300 | - | 113 | - | - | - | 100 | 100 |
|---|
| Purchase of property, plant and equipment | - | -13 | -97 | -196 | -36 | -88 | -213 | -71 | -150 | -91 | -31 | -204 |
|---|
| Purchase of intangible assets | - | -13 | -4 | -4 | -1 | -1 | -8 | -24 | -6 | -14 | -1 | -18 |
|---|
| Purchase of investment securities | - | - | -1,803 | -854 | -427 | -720 | -785 | - | -107 | -201 | -652 | -160 |
|---|
| Proceeds from sale of investment securities | - | 969 | 2,156 | 560 | 61 | 1,097 | 204 | 301 | 388 | 221 | 315 | - |
|---|
| Proceeds from redemption of investment securities | - | - | - | 150 | 185 | 15 | 324 | - | 100 | 115 | 211 | 250 |
|---|
| Other, net | - | -23 | -4 | -4 | - | -0 | -2 | -1 | 0 | 0 | - | -3 |
|---|
| Net cash provided by (used in) investing activities | - | 952 | -796 | 666 | -441 | 534 | -368 | 216 | 225 | -279 | -48 | -135 |
|---|
| Proceeds from long-term borrowings | - | - | - | - | - | - | - | - | - | - | 13 | 50 |
|---|
| Repayments of long-term borrowings | - | - | - | - | - | - | - | - | - | - | -1 | -10 |
|---|
| Proceeds from issuance of shares | - | - | - | - | - | - | - | - | - | - | - | 783 |
|---|
| Proceeds from issuance of shares resulting from exercise of share acquisition rights | - | 272 | 640 | 1,686 | - | 996 | 100 | 692 | 0 | 2 | 4 | 4 |
|---|
| Proceeds from issuance of share acquisition rights | - | 38 | 15 | 15 | - | 11 | - | 4 | - | - | - | 19 |
|---|
| Purchase of treasury shares | - | - | - | - | - | -0 | - | - | - | - | - | - |
|---|
| Repayments of lease liabilities | - | - | - | - | - | - | -1 | -1 | -7 | -18 | -45 | -52 |
|---|
| Net cash provided by (used in) financing activities | - | 309 | 762 | 1,702 | - | 1,007 | 99 | 696 | -7 | -16 | -30 | 793 |
|---|
| Effect of exchange rate change on cash and cash equivalents | - | 63 | 84 | 1 | -34 | -4 | 28 | -11 | -68 | 109 | 36 | 46 |
|---|
| Net increase (decrease) in cash and cash equivalents | - | -855 | -2,031 | 252 | -1,156 | 1,229 | -644 | 371 | -139 | 179 | 1,439 | -15 |
|---|